Product Information
HORIZANT ER 300 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $17.9323 per EA under NDC 53451010301. Its NADAC has been published 593 times since Feb 18, 2015.
Strength
300 mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
53451010301
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTIN ENACARBILApproval Type
New Drug (NDA)
FDA Application
NDA022399On Market Since
5/1/2013
Pharmacological Classes
Price Statistics
The NADAC for HORIZANT ER 300 MG TABLET has been published 593 times since Feb 18, 2015, and over the history we have for it it has risen 137.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.9323 per EA |
|---|---|
| All-time high | $17.9791 (Jun 11, 2025) |
| All-time low | $7.5545 (Feb 18, 2015) |
| 52-week high | $17.9721 |
| 52-week low | $17.9214 |
| Median price | $13.6544 |
| Average price | $13.6707 |
| Largest weekly change | +18.0% (Jan 13, 2016) |
| Weeks tracked | 593 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the gabapentin enacarbil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HORIZANT ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HORIZANT ER 300 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $17.9323 per EA (NDC 53451010301), effective Jun 24, 2026.
How has the price of HORIZANT ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for HORIZANT ER 300 MG TABLET has risen 137.4%. It has been tracked across 593 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for HORIZANT ER 300 MG TABLET?
Since Feb 18, 2015, the NADAC for HORIZANT ER 300 MG TABLET has ranged from a low of $7.5545 (Feb 18, 2015) to a high of $17.9791 (Jun 11, 2025), with a median of $13.6544 per EA.
Are there cheaper alternatives to HORIZANT ER 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HORIZANT ER 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HORIZANT ER 300 MG TABLET?
HORIZANT ER 300 MG TABLET (NDC 53451010301) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification